Systems and Methods for Prosthetic Heart Valve Delivery
Summary
USPTO granted Patent US12599481B2 to 4C Medical Technologies, Inc. for delivery systems and methods for implanting prosthetic heart valves. The patent covers technology for delivering self-expanding prosthetic mitral valve devices to the left atrium without engagement of the left ventricle or native mitral valve leaflets. The patent contains 16 claims and was filed on November 8, 2023.
What changed
USPTO granted Patent US12599481B2 to 4C Medical Technologies, Inc. covering systems, devices and methods for delivering prosthetic heart valve devices to a heart chamber. The technology specifically relates to self-expanding prosthetic mitral valve delivery with no engagement of the left ventricle, native mitral valve leaflets, or annular tissue downstream of the upper annular surface. The patent includes 16 claims and was granted April 14, 2026, with a filing date of November 8, 2023.
Medical device manufacturers developing heart valve delivery systems should review the patent claims to assess potential licensing requirements or design-around opportunities. Healthcare institutions involved in transcatheter mitral valve implantation should monitor this IP development as it may affect available technology options.
What to do next
- Monitor patent portfolio for potential licensing or design-around needs
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
Grant US12599481B2 Kind: B2 Apr 14, 2026
Assignee
4C Medical Technologies, Inc.
Inventors
Jeffrey W. Chambers, Gregory G. Brucker, Joseph P. Higgins, Saravana B. Kumar, Jason S. Diedering, Karl A. Kabarowski, Robert J. Thatcher, James E. Flaherty, Jeffrey R. Stone
Abstract
Embodiments of delivery systems, devices and methods for delivering a prosthetic heart valve device to a heart chamber for expanded implementation are disclosed. More specifically, methods, systems and devices are disclosed for delivering a self-expanding prosthetic mitral valve device to the left atrium, with no engagement of the left ventricle, the native mitral valve leaflets or the annular tissue downstream of the upper annular surface during delivery, and in some embodiments with no engagement of the ventricle, mitral valve leaflets and/or annular tissue located downstream of the upper annular surface by the delivered, positioned and expanded prosthetic mitral valve device.
CPC Classifications
A61B 17/12122 A61F 2/2412 A61F 2/2418 A61F 2/2427 A61F 2/243 A61F 2/2436 A61F 2/2439
Filing Date
2023-11-08
Application No.
18504477
Claims
16
Related changes
Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.